OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
251370$13810.0056

YMT Co Ltd

Specialty ChemicalsVerified

YMT Co Ltd has a market capitalization of KRW 240,071,866,150 and a price-to-book ratio of 1.27, indicating that the market values the company slightly above its book value. The company's liquidity position is characterized by KRW 63,983,672,750 in cash and equivalents, but its long-term debt of KRW 110,114,766,570 suggests a leveraged capital structure. The debt-to-equity ratio of 0.58 indicates moderate leverage, while the current ratio of 1.09 suggests limited short-term liquidity cushion. Profitability metrics show a mixed picture. The company reported a net loss of KRW 1,680,967,450 for the period, with a negative return on equity of -0.89% and a return on assets of -0.45%. These figures are below the typical performance of the specialty chemicals industry, which generally expects positive returns on equity and assets. The operating margin, at 9.03% (calculated from operating income of KRW 13,058,062,570 and revenue of KRW 144,603,566,750), is in line with industry norms but does not offset the net loss. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. The absence of disclosed revenue by region or product line limits the ability to assess the company's exposure to different markets. Looking ahead, the company's growth trajectory is uncertain. The financial data does not provide forward-looking guidance, and the recent net loss raises concerns about its ability to sustain growth. The capital expenditure of KRW -29,259,564,790 (negative due to the sign convention) indicates significant investment in infrastructure or expansion, but the free cash flow of KRW -18,044,102,580 suggests that these investments are not yet generating positive cash returns. The risk assessment highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. The dilution risk is rated as low, with no immediate pressure from share issuance or dilutive events. However, the company's net loss and negative return on equity raise concerns about its long-term financial stability and ability to generate shareholder value. Recent events, as disclosed in the financial statements, include a net loss and a negative return on equity, which may signal operational or market challenges. No recent filings or transcripts were provided in the input data to further contextualize these results.

30-day price · 251370-1240.00 (-8.0%)
Low$13580.00High$23500.00Close$14340.00As of18 May, 00:00 UTC
Profile
CompanyYMT Co Ltd
Ticker251370.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. YMT Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.

Classification. YMT Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

YMT Co Ltd has a market capitalization of KRW 240,071,866,150 and a price-to-book ratio of 1.27, indicating that the market values the company slightly above its book value. The company's liquidity position is characterized by KRW 63,983,672,750 in cash and equivalents, but its long-term debt of KRW 110,114,766,570 suggests a leveraged capital structure. The debt-to-equity ratio of 0.58 indicates moderate leverage, while the current ratio of 1.09 suggests limited short-term liquidity cushion. Profitability metrics show a mixed picture. The company reported a net loss of KRW 1,680,967,450 for the period, with a negative return on equity of -0.89% and a return on assets of -0.45%. These figures are below the typical performance of the specialty chemicals industry, which generally expects positive returns on equity and assets. The operating margin, at 9.03% (calculated from operating income of KRW 13,058,062,570 and revenue of KRW 144,603,566,750), is in line with industry norms but does not offset the net loss. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. The absence of disclosed revenue by region or product line limits the ability to assess the company's exposure to different markets. Looking ahead, the company's growth trajectory is uncertain. The financial data does not provide forward-looking guidance, and the recent net loss raises concerns about its ability to sustain growth. The capital expenditure of KRW -29,259,564,790 (negative due to the sign convention) indicates significant investment in infrastructure or expansion, but the free cash flow of KRW -18,044,102,580 suggests that these investments are not yet generating positive cash returns. The risk assessment highlights a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. The dilution risk is rated as low, with no immediate pressure from share issuance or dilutive events. However, the company's net loss and negative return on equity raise concerns about its long-term financial stability and ability to generate shareholder value. Recent events, as disclosed in the financial statements, include a net loss and a negative return on equity, which may signal operational or market challenges. No recent filings or transcripts were provided in the input data to further contextualize these results.
Key takeaways
  • YMT Co Ltd is a specialty chemicals company with a market capitalization of KRW 240,071,866,150 and a price-to-book ratio of 1.27.
  • The company reported a net loss of KRW 1,680,967,450, with a negative return on equity of -0.89% and a return on assets of -0.45%.
  • The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • The company has a negative free cash flow of KRW -18,044,102,580 and a negative net cash position after accounting for total debt.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$144.60B
Gross profit$39.04B
Operating income$13.06B
Net income-$1.68B
R&D
SG&A
D&A
SBC
Operating cash flow$17.53B
CapEx-$29.26B
Free cash flow-$18.04B
Total assets$373.64B
Total liabilities$184.46B
Total equity$189.18B
Cash & equivalents$63.98B
Long-term debt$110.11B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$144.60B$13.06B-$1.68B-$18.04B
FY-1$137.23B$4.29B-$4.34B-$30.06B
FY-2$127.41B-$3.17B-$2.89B-$19.24B
FY-3$130.57B$3.20B-$52.2M-$13.41B
FY-4$125.57B$16.88B$9.70B-$2.23B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$373.64B$189.18B$63.98B
FY-1$350.57B$171.71B$40.19B
FY-2$249.91B$122.86B$39.56B
FY-3$247.91B$125.08B$53.12B
FY-4$246.26B$113.20B$70.16B
PeriodOCFCapExFCFSBC
FY0$17.53B-$29.26B-$18.04B
FY-1$7.03B-$37.05B-$30.06B
FY-2$7.64B-$27.78B-$19.24B
FY-3$13.49B-$23.90B-$13.41B
FY-4$22.41B-$23.11B-$2.23B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$34.98B$2.59B$2.17B$220.8M
FQ-1$38.40B$4.22B-$4.44B$986.2M
FQ-2$36.14B$3.26B$882.4M-$2.48B
FQ-3$35.10B$4.03B$1.25B-$5.66B
FQ-4$34.96B$1.55B$620.6M-$10.62B
FQ-5$36.53B$1.52B-$439.8M-$12.00B
FQ-6$36.37B$1.82B$1.85B-$1.28B
FQ-7$34.81B$930.8M-$4.88B-$7.77B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$361.38B$194.36B$44.92B
FQ-1$373.64B$189.18B$63.98B
FQ-2$363.44B$186.20B$50.84B
FQ-3$360.02B$168.37B$41.77B
FQ-4$362.39B$170.36B$56.95B
FQ-5$350.57B$171.71B$40.19B
FQ-6$343.93B$179.73B$52.84B
FQ-7$259.40B$119.42B$31.70B
PeriodOCFCapExFCFSBC
FQ0-$13.77B-$5.34B$220.8M
FQ-1$17.53B-$29.26B$986.2M
FQ-2$12.98B-$30.82B-$2.48B
FQ-3$6.11B-$23.93B-$5.66B
FQ-4$5.93B-$14.07B-$10.62B
FQ-5$7.03B-$37.05B-$12.00B
FQ-6$4.30B-$22.52B-$1.28B
FQ-7$1.39B-$16.49B-$7.77B
Valuation
Market price$13810.00
Market cap$240.07B
Enterprise value$286.20B
P/E
Reported non-GAAP P/E
EV/Revenue2.0
EV/Op income21.9
EV/OCF16.3
P/B1.3
P/Tangible book1.3
Tangible book$189.18B
Net cash-$46.13B
Current ratio1.1
Debt/Equity0.6
ROA-0.4%
ROE-0.9%
Cash conversion-10.4%
CapEx/Revenue-20.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric251370Activity
Op margin9.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-1.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin27.0%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-20.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity58.0%59.0% medp25 54.9% · p75 72.9%below median
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 01:25 UTCJob: c9321a30